HomeAARD • NASDAQ
add
Aardvark Therapeutics Inc
Previous close
$12.40
Day range
$12.32 - $13.77
Year range
$4.88 - $19.58
Market cap
295.25M USD
Avg Volume
183.46K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 17.70M | 247.73% |
Net income | -16.32M | -290.15% |
Net profit margin | — | — |
Earnings per share | -0.75 | — |
EBITDA | -17.69M | -247.72% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 126.35M | 53.41% |
Total assets | 133.23M | 59.10% |
Total liabilities | 10.85M | 243.74% |
Total equity | 122.38M | — |
Shares outstanding | 21.77M | — |
Price to book | 2.20 | — |
Return on assets | -31.53% | — |
Return on capital | -33.98% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -16.32M | -290.15% |
Cash from operations | -16.13M | -307.84% |
Cash from investing | 29.25M | 585,020.00% |
Cash from financing | 171.00K | 167.19% |
Net change in cash | 13.29M | 441.04% |
Free cash flow | -9.05M | -205.35% |
About
Founded
2017
Website
Employees
33
